QQ客服 官方微博 反馈留言

	Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials
	Huang, Qingyuan; Zhang, Hua; Hai, Josephine; Socinski, Mark A.; Lim, Eric; Chen, Haiquan; Stebbing, Justin
刊名	ONCOIMMUNOLOGY
	2018
卷号	7期号:12
关键词	anti-PD-1 atezolizumab immunotherapy nivolumab non-small cell lung cancer pembrolizumab
ISSN号	2162-402X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3602612
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Huang, Qingyuan,Zhang, Hua,Hai, Josephine,et al. Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials[J]. ONCOIMMUNOLOGY,2018,7(12).
APA	Huang, Qingyuan.,Zhang, Hua.,Hai, Josephine.,Socinski, Mark A..,Lim, Eric.,...&Stebbing, Justin.(2018).Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials.ONCOIMMUNOLOGY,7(12).
MLA	Huang, Qingyuan,et al."Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials".ONCOIMMUNOLOGY 7.12(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。